Back
Virtus Dividend, Interest & Premium Strategy Fund Vs. Viking Therapeutics Industry Stock Comparison
Sell
50
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
Last Price:
12.80
Seasonality Move:
1.03%
Buy
53
VKTX
Viking Therapeutics
Last Price:
64.95
Seasonality Move:
34.33%
Sell
50
Virtus Dividend, Interest & Premium Strategy Fund (NFJ)
is a Sell
Is Virtus Dividend, Interest & Premium Strategy Fund a Buy, Sell or Hold?
- The current Virtus Dividend, Interest & Premium Strategy Fund [NFJ] share price is $12.79. The Score for NFJ is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NFJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $64.96. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NFJ Stock Price Chart
What is Virtus Dividend, Interest & Premium Strategy Fund's stock price today?
-
The Virtus Dividend, Interest & Premium Strategy Fund share price today is $12.79
The current trend is moderately bearish and NFJ is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $64.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NFJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 48.08 | Sell |
Chaikin Money Flow: | -35636 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.77 - 12.95) | Sell |
Bollinger Bands (100): | (12.26 - 12.8) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.97 | Buy |
Relative Strength Index (14 RSI): | 54.51 | Buy |
Chaikin Money Flow: | 1135470 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.05 - 66.47) | Buy |
Bollinger Bands (100): | (52.64 - 64.98) | Buy |
NFJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.9 | Sell |
20-day SMA: | 12.86 | Sell |
50-day SMA: | 12.72 | Buy |
200-day SMA: | 12.42 | Buy |
8-day EMA: | 12.87 | Sell |
20-day EMA: | 12.85 | Sell |
50-day EMA: | 12.74 | Buy |
200-day EMA: | 12.41 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 63.29 | Buy |
20-day SMA: | 63.32 | Buy |
50-day SMA: | 60.76 | Buy |
200-day SMA: | 55.03 | Buy |
8-day EMA: | 63.88 | Buy |
20-day EMA: | 63.16 | Buy |
50-day EMA: | 61.34 | Buy |
200-day EMA: | 52.6 | Buy |
Virtus Dividend, Interest & Premium Strategy Fund Earnings Growth & NFJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Virtus Dividend, Interest & Premium Strategy Fund Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |